Position
Renaissance Technologies in ImageneBio, Inc.
Back to the book · All holders of IMA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $73.5K$5.00 → $5.90
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 66.1K | $456.1K | — | — | — | 0.0% |
| Q1 2026 | 81.7K | $408.5K | $5.00 | −$125.6K | $78K | 0.0% |
| Q2 2026 | 86.9K | $512.9K | $5.90 | $73.5K | $30.9K | 0.0% |